Published in Hospital Business Week, November 23rd, 2008
"With PEARL 2 fully enrolled, we have now completed enrollment in our pivotal Phase 3 non-dialysis trials," said Anne-Marie Duliege, M.D., chief medical officer at Affymax. "We are now focusing our attention on finalizing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week